Endocrine Society applauds Eli Lilly’s efforts to lower insulin costs
Endocrine SocietyThe Endocrine Society commends Eli Lilly and Company for taking steps to reduce insulin prices and make insulin affordable for more people with diabetes.
The Endocrine Society commends Eli Lilly and Company for taking steps to reduce insulin prices and make insulin affordable for more people with diabetes.
Endocrine-disrupting chemicals (EDCs) in plastics may contribute to diabetes risk in women, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
The Endocrine Society applauds President Biden’s call to rein in soaring insulin prices for those with private insurance and urges Congress to take immediate action.
Endocrine Society experts will discuss how a new generation of anti-obesity medications are changing treatment during a virtual Science Writers Conference on February 7.
R. Scott Struthers, Ph.D., has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for his contributions to drug discovery and development programs for endocrine diseases, the Society announced today.
Members of the media can now register to cover the latest advances in hormone health and science at ENDO 2023, the Endocrine Society’s annual meeting being held June 15-18, in Chicago, Illinois.
Experts provide the first framework for treating a common and life-threatening metabolic complication of cancer known as hypercalcemia of malignancy in the Endocrine Society’s new Clinical Practice Guideline.
After an intermittent fasting diet intervention, patients achieved complete diabetes remission, defined as an HbA1c (average blood sugar) level of less than 6.5% at least one year after stopping diabetes medication, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Wearable fitness devices offer new insights into the relationship between physical activity and type 2 diabetes, according to a new analysis of the National Institutes of Health’s All of Us Research Program data published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society.
Results of pancreas transplantation continue to improve and up to 90% of recipients with diabetes enjoy freedom from both insulin therapy and the need for close glucose monitoring following the procedure, according to a new paper published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
The Endocrine Society rebukes the Florida Board of Medicine’s decision to ban gender-affirming care for transgender and gender-diverse teenagers.
Endocrine experts will deliver free health services in West Baltimore during EndoCares® Baltimore, an in-person health education event being held on November 5.
The Endocrine Society and the European Society of Endocrinology (ESE) have jointly awarded the 2023 Transatlantic Alliance Award—to Prof. George P. Chrousos, M.D., Sc.D.
Los expertos en salud brindarán servicios de salud gratuitos a la comunidad, incluyendo los residentes de Phoenix durante EndoCares® Phoenix, un evento de educación para la salud que se llevará a cabo el 22 de octubre.
Endocrine experts will deliver free health services to underrepresented communities, including LatinX residents, during EndoCares® Phoenix, an in-person health education event being held on October 22.
Women with polycystic ovary syndrome (PCOS) in Alabama may be more likely to have excessive hair growth and insulin resistance, whereas women with PCOS in California may be more likely to have higher testosterone levels, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
The Endocrine Society today announced it has chosen 13 leading endocrinologists as winners of its prestigious 2023 Laureate Awards, the top honors in the field.
Following rapid growth during the COVID-19 pandemic, telehealth visits are expected to remain an important part of endocrine care, according to a new Endocrine Society policy perspective published in The Journal of Clinical Endocrinology & Metabolism.